Introduction Dorsal agenesis of the pancreas (DAP) is a rare congenital anomaly, with only 44 cases having been reported in the English literature since 1966. Materials and Methods A retrospective review of our IRB-approved pancreatic surgery database was performed from November 2005 to November 2010 searching for cases of DAP. Discussion Disorders in the retinoic acid (Raldh) and hedgehog (Hh) signaling pathways, which appear to play a role in the development of DAP, have been implicated in other diseases of the pancreas such as pancreatic ductal adenocarcinoma (PDA) and nonalcoholic chronic calcific pancreatitis (NCCP). Conclusion In this report, we describe three cases of DAP in the setting of PDA, two of which include the third component of NCCP. We provide a discussion of the clinical features of this novel triad and address the molecular pathways that relate to these respective diseases.
Introduction
Congenital abnormalities of the pancreas are quite rare. The most common congenital abnormality is pancreas divisum, which has a reported incidence of 1.3-5.8%. 1 Other pancreatic congenital abnormalities are significantly less common, such as annular pancreas, ectopic pancreas, and dorsal agenesis of the pancreas (DAP). Forty-four cases of DAP have been reported in the English literature since 1966. The most common presenting symptom of this condition is abdominal pain, with nearly 68% of patients presenting with vague abdominal discomfort. Additionally, one third of patients are found to have diabetes mellitus at the time of presentation. 2 The diagnosis of DAP is often made by computed tomography (CT) or magnetic resonance imaging (MRI) during the evaluation for abdominal pain, though a significant number of cases have also been identified incidentally during the workup for an unrelated problem. DAP is typically suspected when no pancreatic tissue is seen to the left of the superior mesenteric vessels (Fig. 1) . The exact etiology of DAP remains unclear; however, the retinoic acid (Raldh) and hedgehog (Hh) signaling pathways have been shown to play a role in its pathogenesis. These signaling pathways have also been implicated in the pathogenesis of pancreatic ductal adenocarcinoma (PDA) and nonalcoholic chronic calcific pancreatitis (NCCP).
While DAP remains a rare disease, NCCP and PDA occur more commonly. NCCP occurs primarily in tropical countries, with a prevalence of 10-15 per 100,000 people. NCCP is characterized by irreversible destruction of the pancreatic parenchyma leading to pancreatic endocrine and exocrine insufficiency. 3 Patients may classically present with a constellation of symptoms including abdominal pain, steatorrhea, and diabetes mellitus. NCCP carries an increased risk for the development of PDA. Chari et al. followed 185 patients for 4.5 years to assess the risk for the development of PDA. 4 During the follow-up period, 25% of patients died from PDA. Although PDA is only the 10th most common cancer in the USA, it remains the fourth leading cause of cancer death. Less than 20% of patients with PDA are candidates for curative surgical resection at the time of diagnosis, and the overall 5-year survival rate is a dismal 4%.
Developing a better understanding of the processes that link these seemingly disparate diseases may offer insight into their early detection and clinical management. In this report, we describe three patients with PDA in the setting of DAP, two of whom had the novel triad of DAP, PDA, and NCCP. Herein, we also place these three patients in the context of the world literature of patients with DAP and PDA.
Materials and Methods
In this study, we performed a retrospective review of the prospectively acquired, IRB-approved pancreatic surgery database in the Department of Surgery of Thomas Jefferson University from 28 November 2005 to 31 November 2010, searching for cases of DAP. We reviewed patient demographics, preoperative studies, operative variables, adjuvant therapy, and survival. We identified three cases of DAP out of 870 patients who underwent surgical resection for pancreatic diseases during the study period. A literature review was conducted searching the English language literature for all cases of DAP with associated pancreatic neoplasms from 1966 to the present. We used the search terms "dorsal agenesis of the pancreas," "pancreatic ductal adenocarcinoma," and "nonalcoholic chronic calcific pancreatitis."
Clinical Material and Results

Case 1
A 37-year-old woman originally from the Indian subcontinent, with a history of insulin dependent diabetes, presented with a history of vague epigastric abdominal pain of 2 months duration. A CT scan ( Fig. 1) was performed that showed a 1-cm cystic mass in the uncinate process of the pancreas, associated with peripancreatic fat stranding, consistent with acute pancreatitis. Dorsal agenesis of the pancreas was noted on CT scan as well. Endoscopic retrograde cholangiopancreatography (ERCP) demonstrated a dilated and truncated main pancreatic duct with intraductal calculi (Fig. 2) . A pancreatic ductal sphincterotomy was performed with stone extraction and placement of a biliary endoprosthesis. An endoscopic ultrasound (EUS) procedure revealed a 2.2×2.1 cm hypoechoic mass in the uncinate process, with calcifications and an absent pancreatic body and tail. Fine-needle aspiration (FNA) of the mass at the time of EUS revealed atypical cells suspicious for adenocarcinoma. The patient's CA19-9 level was normal at 3 U/mL, but the carcinoembryonic antigen (CEA) level was elevated at 8.2 ng/mL. On operative exploration, a firm mass was identified in the uncinate process of the pancreas, and there was no evidence of metastatic disease. The pancreatic body and tail appeared to be replaced with fat (Fig. 3) . A pyloruspreserving resection of the pancreatic head and uncinate process was performed with an end-to-side hepaticojejunostomy and a downstream retrocolic duodenojejunostomy. Pathology revealed a 3-cm moderately differentiated ductal adenocarcinoma involving the uncinate process of the pancreas with negative surgical margins of resection. One of 21 specimen lymph nodes was positive for metastatic disease leading to an American Joint Commission on Cancer (AJCC) pathologic stage of IIb (T3N1M0). The pancreatic neck margin showed benign adipose tissue with no evidence of pancreatic glandular tissue, consistent with an aplastic body and tail. The patient's postoperative course was uneventful, and she was discharged to home on postoperative day 7, on parental insulin therapy and exogenous pancreatic enzyme supplementation. She received adjuvant treatment with gemcitabine-based chemotherapy but died of recurrent malignant disease 17 months postresection.
Case 2
A 59-year-old woman, also originally from the Indian subcontinent and with a history of insulin dependent diabetes mellitus, presented with a 4-month history of abdominal pain and weight loss. The patient had previously undergone a CT scan 2 years earlier which showed a small cystic lesion in the pancreatic head with surrounding calcifications. Repeat CT scan demonstrated a 4×4 cm mass in the head of the pancreas with multiple calcifications causing biliary dilatation and duodenal narrowing, as well as agenesis of the body and tail of the pancreas. Tumor marker analysis revealed a mildly elevated CA19-9 level of 62 U/mL and a normal CEA level of 1.8 ng/mL. The patient underwent operative exploration which revealed a firm mass occupying the entire head and uncinate process of the pancreas, with the pancreatic body and tail replaced by fat. A pylorus-preserving resection of the pancreatic head and uncinate process was performed with a hepaticojejunostomy and duodenojejunostomy. Pathology revealed an 8.5×6 cm moderately differentiated ductal adenocarcinoma of the pancreas. The surgical margins of resection were negative and 1/13 specimen lymph nodes harbored metastatic disease leading to an AJCC pathologic stage of IIb (T3N1M0). No pancreatic tissue was present at the pancreatic neck margin. The patient recovered from surgery uneventfully and was discharged to home on postoperative day 6, on parental insulin therapy and exogenous pancreatic enzyme supplementation. She received adjuvant gemcitabine-based chemotherapy and radiation and remained alive 38 months postresection.
Case 3
A 68-year-old Caucasian man was found to have abnormal liver function tests on routine laboratory analysis performed by his primary care physician. His total and direct bilirubin (2.8/1.8 mg/dL), alkaline phosphatase (461 IU/L), aspartate aminotransferase (227 IU/L), and alanine aminotransferase (418 IU/L) were all elevated. Tumor marker analysis revealed an elevated CA19-9 level of 439 U/mL and a mildly elevated CEA level of 3.1 ng/mL. CT scan revealed a dilated extrahepatic biliary tree with a calcified cystic lesion within the head of the pancreas extending into the uncinate process. The patient underwent an ERCP with sphincterotomy and placement of a biliary endoprosthesis. Upon surgical exploration, the mass in the head of the pancreas was identified, and there was noted to be an absence of pancreatic tissue to the patient's left of the superior mesenteric vessels. As in the two previous cases, a pylorus-preserving resection of the pancreatic head and uncinate process was performed with a hepaticojejunostomy and duodenojejunostomy. Pathology revealed a 2.1-cm moderately differentiated ductal adenocarcinoma of the pancreas with negative surgical margins of resection. None of the 17 specimen lymph nodes harvested harbored metastatic disease, leading to an AJCC pathologic stage of Ib (T2N0M0). The patient was discharged to home on postop- Table 1 depicts all of the previously published cases of DAP and associated PDA or NCCP, including our own three cases. Two cases of prior PDA in the setting of DAP have been documented in the English literature, the first having been reported by Matsusue in 1984. 5, 6 Since that time, various neoplastic lesions have also been reported including leiomyosarcoma, endocrine tumors, and intraductal papillary mucinous neoplasms in association with DAP. Most cases of concurrent pancreatic neoplasm and DAP in the literature, including our own, underwent a resection of all remaining pancreatic tissue. Balakrishnan reported a case of DAP in the setting of NCCP. 7 
Discussion
This study documents three patients with DAP and PDA (Fig. 4) , two of whom had the novel triad of DAP, PDA, and NCCP. Although they never underwent genetic testing, our two patients with NCCP fit the criteria for this diagnosis, in that, they were from an area endemic for NCCP and had chronic abdominal pain, diabetes, and earlyonset PDA. The patient who had an ERCP had the presence of large intraductal calculi. All three of our patients underwent successful operative treatment with pyloruspreserving resection of the pancreatic head and uncinate process with construction via a hepaticojejunostomy and duodenojejunostomy. A short description of pancreatic organogenesis and a discussion of the molecular and genetic mechanisms that play a role in the development of these three separate but related entities follow.
The pancreas begins its development in the fourth week of gestation, starting as two separate buds arising from the primordial foregut (Fig. 5) . The ventral pancreatic bud develops from the hepatic diverticulum arising from the duodenum, and the dorsal pancreatic bud arises separately from the dorsal aspect of the duodenum. 8 As the duodenum rotates to the right assuming the C shape, the ventral pancreatic bud continues its rotation before fusing with the dorsal pancreatic bud. 9 The dorsal pancreatic bud forms the body and tail of the pancreas and also gives rise to the accessory pancreatic duct which empties into the minor duodenal papilla of Santorini. 8 Any failure in the development of the dorsal bud therefore leads to an absence of a functional pancreatic body, tail, and accessory pancreatic duct. While complete agenesis of the pancreas is a rare congenital disorder that is associated with impaired intrauterine growth and is often fatal, 10 DAP results in only partial impairment of pancreatic function and may often go undetected. The specific etiology of DAP remains unclear, In mouse models, certain genetic alterations or knockouts are linked to the failure of dorsal pancreatic development. Reduced expression of homeobox gene Hlxb9 in mice causes failure of dorsal pancreatic development, 11 whereas normal retinoic acid signaling through the Raldh2 gene leads to the development of the dorsal pancreatic bud. Martin et al. showed that mice with the Raldh2 knockout fail to develop a dorsal pancreatic bud. 12 Also, early expression of either sonic (Shh) or indian (Ihh) hedgehog, two members of the hedgehog (Hh) cell signaling family, can suppress pancreas development. 13 In addition to DAP, alterations in the Raldh2 and Hh signaling pathways are also implicated in the development of NCCP and PDA, respectively.
Singh et al. demonstrated that increased retinoic acid concentrations inhibited the growth of pancreatic cancer cells in vitro.
14 Conversely, one could hypothesize that perhaps a defect in the retinoic acid signaling pathway may lead to an increased risk of developing pancreatic cancer in patients who have DAP. Despite belonging to different molecular pathways, the Hh and Raldh2 genes represent some of the complementary molecular "on" and "off" mechanisms that are involved in pancreatic development and function. Importantly, when these molecular mechanisms are abnormal, they can lead to aberrant pancreatic phenotypes.
The development of NCCP and other forms of chronic pancreatitis has been associated with a number of genetic alterations. Mutations in SPINK1, a serine protease inhibitor that suppresses intrapancreatic trypsin activity, have been associated with the development of NCCP. 15 Bhatia et al. examined 66 unrelated patients in northern India with a history of NCCP and compared them to 92 healthy control patients from the same region. 15 They found that 50% of the patients with NCCP had a heterozygous NS34S Fig. 4 Illustration of DAP. There is an absence of pancreatic tissue to the left of the neck of the gland. In this case, a cancer of the head of the pancreas is also depicted SPINK1 mutation, and 14% had a homozygous mutation. Only 2.2% of the healthy control patients had the mutation. Ihh and its receptors patched (Ptc) and smoothened (Smo) are overexpressed in tissues from patients with chronic pancreatitis but weakly expressed in normal ductal cells. 13 Increased Hh signaling marks the progression of normal to fibrotic tissue in chronic pancreatitis. 7 These suggest that perhaps the development of these diseases, DAP, PDA, and NCCP, may be rooted in certain common pathways of pancreatic development and function All three patients in the current study underwent pyloruspreserving resection of the pancreatic head and uncinate process. Parsaik et al. reported the metabolic consequences following total pancreatectomy. 16 One hundred forty-one patients were retrospectively studied, and nearly 89% of patients were on a complex insulin regimen with a mean daily insulin requirement of 35 U. Seventy-nine percent of these patients reported episodic hypoglycemia, which demonstrates the difficulty in balancing postoperative glucose management. Twenty-eight percent of patients reported chronic diarrhea from lack of pancreatic exocrine function postoperatively. It is vital that the patient be educated regarding the metabolic consequences of undergoing a total pancreatectomy prior to surgical intervention.
Difficulty can arise in trying to distinguish congenital agenesis of the pancreas from acquired fatty replacement of the pancreas. Small to large amounts of fat replacement can normally occur in obese and elderly patients. 16 Total fat replacement of the dorsal pancreas has been reported but is quite rare. A proposed mechanism for the replacement of normal pancreatic endocrine and exocrine tissue with adipose tissue is chronic obstruction of the pancreatic duct. Blockage can arise from calculi or tumors. Pancreatic duct obstruction by a stone can cause fibrosis in canine models. 17 Ligation of the pancreatic duct in mice causes complete intralobular replacement. 18 Proposed criteria for confirming true congenital DAP as opposed to fatty replacement include the complete absence of exocrine features, acinar cells, and islets of Langerhans on histologic examination. 19 Suggested radiologic criteria to diagnose dorsal agenesis of the pancreas have included the lack of a dorsal and transverse pancreatic artery on angiography (rarely performed) and the absence of an accessory pancreatic duct on ERP. 19 However, the most common means of diagnosis is by cross-sectional imaging (CT or MRI/MRCP).
Conclusion
In summary, this review documents three patients with DAP and PDA, two of whom had the novel triad of DAP, PDA, and NCCP. All three patients underwent successful operative treatment via pylorus-preserving resection of the pancreatic head and uncinate process. This series raises a number of interesting questions. Is there a potential common molecular pathway in the development of dorsal agenesis of the pancreas and the development of PDA involving the retinoic acid signaling pathway? Did the malignant transformation in two of our patients have a greater association with DAP or NCCP? Patients with known DAP may benefit from early screening given the apparent increased risk of developing pancreatic cancer.
